Feeding the Rainbow to Investigate Endothelial Dysfunction (FRIED)

February 2, 2012 updated by: Ryan David Bradley, Bastyr University

Evaluating the Effects of Mixed-Carotenoids on Biomarkers of Endothelial Dysfunction

The primary purpose of this study is to compare the change in blood carotene concentration between a food-based versus nutritional supplement-based intervention. This study will randomize up to 60 healthy volunteers to receive either carotenoid-enriched food; natural, mixed carotenoid supplementation; chlorophyll complex or placebo supplementation. Blood carotene levels will be measured before and after 28 days of supplementation. Preliminary data will also be collected on several biomarkers associated with vascular inflammation and endothelial dysfunction. These biomarkers will be measured before and during a fast food control meal at the beginning and end of the intervention period.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Kenmore, Washington, United States, 98028
        • Bastyr University Clinical Research Center
      • Seattle, Washington, United States, 98195
        • University of Washington Clinical Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adults aged 18-65
  • in good health by the absence of exclusion criteria on standardized medical history interview
  • willingness to be randomized
  • willingness to complete multiple blood draws following fast food consumption on two occasions over 28 days

Exclusion Criteria:

  • children <18 years
  • current use of carotenoid supplements (not including typical multivitamins containing beta-carotene)
  • current use of polyphenol supplements including green tea, resveratrol, pine bark extract, cocoa, and/or grape skin extract
  • current use of aspirin, statins or regular (>2 per week) use of NSAID medications
  • current smoking or past smoking greater than 3 packs total or currently living with a smoker
  • excessive alcohol intake (> 3 drinks per day) or history of alcoholism
  • known exposure to asbestos
  • autoimmune disease
  • hemachromatosis
  • history of gallbladder disease including gall stones or gall bladder removal
  • pre-diabetes, metabolic syndrome or diabetes (1 or 2)
  • established cardiovascular disease (arrhythmia, heart failure, hypertension treatment or untreated stage II hypertension (≥160/90; stage II technically diastolic ≥100mmHg, will maintain diastolic cutoff of 90mmHg), past MI or stroke)
  • renal or liver disease (viral hepatitis, non-alcoholic steatohepatitis "fatty liver")
  • acute infection except viral colds
  • residual injury/pain/limitation from trauma
  • chronic musculoskeletal disorders including osteoarthritis requiring pain medications
  • psychiatric disorders that would impair completion of research tasks
  • allergies to supplied foods
  • anyone on a medically-prescribed diet
  • >3.5 servings fruits/veggies per day
  • inability to consume entire study Control meal w/in specified timeline (30 minutes)
  • current pregnancy or breast feeding
  • refusal to participate in blood draws following the control meal.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Safflower oil-filled capsules, one twice daily with meals
Active Comparator: Supplement 1
One capsule, twice daily with meals for 28 days
Active Comparator: Supplement 2
One capsule per day with meals for 28 days
Active Comparator: Food-based Intervention
Single carotenoid-enriched soup or salad serving eaten daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in serum carotenoid fraction concentrations between study arms
Time Frame: Following 28 day intervention
Following 28 day intervention

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in oxidized LDL lipoproteins (oxLDL)
Time Frame: Following 28 day intervention
Following 28 day intervention
Change in serum gamma-glutamyl transferase (GGT)
Time Frame: Following 28 day intervention
Following 28 day intervention
Change in urinary isoprostanes
Time Frame: Following 28 day intervention
Following 28 day intervention
Change in serum antioxidant capacity (ORAC)
Time Frame: Following 28 day intervention
Following 28 day intervention
Change in lipid profile (LDL, HDL, triglycerides)
Time Frame: Following 28 day intervention
Following 28 day intervention
Change in C-reactive protein (CRP)
Time Frame: Following 28 day intervention
Following 28 day intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ryan D Bradley, ND, MPH, Bastyr University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

August 1, 2011

Study Registration Dates

First Submitted

August 3, 2010

First Submitted That Met QC Criteria

August 3, 2010

First Posted (Estimate)

August 5, 2010

Study Record Updates

Last Update Posted (Estimate)

February 3, 2012

Last Update Submitted That Met QC Criteria

February 2, 2012

Last Verified

February 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on Chlorophyll complex, Standard Process

Subscribe